DataKnowledgeCloudtrainingcoordination

COL O14974-1 GLY 000708 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

MYPT1 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

human proteoform glycosylation sites oglcnac atlas.csv

File (Entity type)

Description:Information for protein O14974-1 in the context of file GLY_000708

Creation Time:2026-03-02 19:57:26.000000

Results found

Linked to

	Label	Description
	stem cell Anatomy (Entity type)	A relatively undifferentiated cell that retains the ability to divide and proliferate throughout lif...
	MYPT1 HUMAN Protein (Entity type)	Protein phosphatase 1 regulatory subunit 12A
	o14974-1 775ser 775ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 571thr 571thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 564ser 564ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 464thr 464thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 565ser 565ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 566ser 566ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 773ser 773ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	o14974-1 585ser 585ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Anatomy

stem cell

Anatomy (Entity type)

A relatively undifferentiated cell that retains the ability to divide and proliferate throughout lif...

Protein

MYPT1 HUMAN

Protein (Entity type)

Protein phosphatase 1 regulatory subunit 12A

Post Translational Modification

o14974-1 775ser 775ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 571thr 571thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 564ser 564ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 464thr 464thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 565ser 565ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 566ser 566ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 773ser 773ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

o14974-1 585ser 585ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.